180 related articles for article (PubMed ID: 12975333)
1. In vitro metabolism studies on the isoxazole ring scission in the anti-inflammatory agent lefluonomide to its active alpha-cyanoenol metabolite A771726: mechanistic similarities with the cytochrome P450-catalyzed dehydration of aldoximes.
Kalgutkar AS; Nguyen HT; Vaz AD; Doan A; Dalvie DK; McLeod DG; Murray JC
Drug Metab Dispos; 2003 Oct; 31(10):1240-50. PubMed ID: 12975333
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of leflunomide by mouse and human liver microsomes.
Chan EC; New LS
Drug Metab Lett; 2007 Dec; 1(4):299-305. PubMed ID: 19356059
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of a novel bioactivation pathway of a 3,4-unsubstituted isoxazole in human liver microsomes: formation of a glutathione adduct of a cyanoacrolein derivative after isoxazole ring opening.
Yu J; Folmer JJ; Hoesch V; Doherty J; Campbell JB; Burdette D
Drug Metab Dispos; 2011 Feb; 39(2):302-11. PubMed ID: 21045198
[TBL] [Abstract][Full Text] [Related]
4. A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner.
Hamilton LC; Vojnovic I; Warner TD
Br J Pharmacol; 1999 Aug; 127(7):1589-96. PubMed ID: 10455314
[TBL] [Abstract][Full Text] [Related]
5. The active metabolite of leflunomide, A771726, inhibits both the generation of and the bone-resorbing activity of osteoclasts by acting directly on cells of the osteoclast lineage.
Kobayashi Y; Ueyama S; Arai Y; Yoshida Y; Kaneda T; Sato T; Shin K; Kumegawa M; Hakeda Y
J Bone Miner Metab; 2004; 22(4):318-28. PubMed ID: 15221489
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
[TBL] [Abstract][Full Text] [Related]
7. Substituent effect on the reductive N-dearylation of 3-(indol-1-yl)-1,2-benzisoxazoles by rat liver microsomes.
Tschirret-Guth RA; Wood HB
Drug Metab Dispos; 2003 Aug; 31(8):999-1004. PubMed ID: 12867488
[TBL] [Abstract][Full Text] [Related]
8. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase.
Davis JP; Cain GA; Pitts WJ; Magolda RL; Copeland RA
Biochemistry; 1996 Jan; 35(4):1270-3. PubMed ID: 8573583
[TBL] [Abstract][Full Text] [Related]
9. The active metabolite of leflunomide A771726 inhibits corneal neovascularization.
Zhang M; Hao N; Bian F
J Huazhong Univ Sci Technolog Med Sci; 2008 Jun; 28(3):364-8. PubMed ID: 18563344
[TBL] [Abstract][Full Text] [Related]
10. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides.
Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D
Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831
[TBL] [Abstract][Full Text] [Related]
11. A 771726, the active metabolite of leflunomide, inhibits TNF-alpha and IL-1 from Kupffer cells.
Yao HW; Li J; Chen JQ; Xu SY
Inflammation; 2004 Apr; 28(2):97-103. PubMed ID: 15379215
[TBL] [Abstract][Full Text] [Related]
12. [The active metabolite of leflunomide A771726 inhibits proliferation and collagen synthesis of hepatic stellate cell].
Yao HW; Li J; Chen JQ; Xu SY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 33(6):515-8, 528. PubMed ID: 15586409
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of potential new therapeutic targets in inflammatory and autoimmune diseases.
Mangold U; Dax CI; Saar K; Schwab W; Kirschbaum B; Müllner S
Eur J Biochem; 1999 Dec; 266(3):1184-91. PubMed ID: 10583416
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of leflunomide active metabolite A771726 on high glucose-induced podocyte apoptosis].
Yuan YC; Yu WM; Li RS; Qiao X
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(10):703-6. PubMed ID: 21600180
[TBL] [Abstract][Full Text] [Related]
15. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
[TBL] [Abstract][Full Text] [Related]
16. Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193.
Machinist JM; Mayer MD; Shet MS; Ferrero JL; Rodrigues AD
Drug Metab Dispos; 1995 Oct; 23(10):1163-74. PubMed ID: 8654206
[TBL] [Abstract][Full Text] [Related]
17. Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid.
Taguchi K; Konishi T; Nishikawa H; Kitamura S
Xenobiotica; 1999 Sep; 29(9):899-907. PubMed ID: 10548450
[TBL] [Abstract][Full Text] [Related]
18. Metabolism studies of a small-molecule tumor necrosis factor-alpha (TNF-α) inhibitor, UTL-5b (GBL-5b).
Shaw J; Shay B; Jiang J; Valeriote F; Chen B
Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):83-9. PubMed ID: 22052362
[TBL] [Abstract][Full Text] [Related]
19. Dehydration of alkyl- and arylaldoximes as a new cytochrome P450-catalyzed reaction: mechanism and stereochemical characteristics.
Boucher JL; Delaforge M; Mansuy D
Biochemistry; 1994 Jun; 33(25):7811-8. PubMed ID: 8011645
[TBL] [Abstract][Full Text] [Related]
20. Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Xenobiotica; 2001 Oct; 31(10):713-23. PubMed ID: 11695850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]